184 related articles for article (PubMed ID: 17164365)
1. A NAD(P)H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer.
Begleiter A; Hewitt D; Maksymiuk AW; Ross DA; Bird RP
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2422-6. PubMed ID: 17164365
[TBL] [Abstract][Full Text] [Related]
2. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese.
Hamajima N; Matsuo K; Iwata H; Shinoda M; Yamamura Y; Kato T; Hatooka S; Mitsudomi T; Suyama M; Kagami Y; Ogura M; Ando M; Sugimura Y; Tajima K
Int J Clin Oncol; 2002 Apr; 7(2):103-8. PubMed ID: 12018106
[TBL] [Abstract][Full Text] [Related]
3. An association between a NQO1 genetic polymorphism and risk of lung cancer.
Saldivar SJ; Wang Y; Zhao H; Shao L; Lin J; Spitz MR; Wu X
Mutat Res; 2005 Apr; 582(1-2):71-8. PubMed ID: 15781212
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptive use and breast cancer risk: modification by NAD(P)H:quinone oxoreductase (NQO1) genetic polymorphisms.
Fowke JH; Shu XO; Dai Q; Jin F; Cai Q; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1308-15. PubMed ID: 15298951
[TBL] [Abstract][Full Text] [Related]
5. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.
Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA
Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823
[TBL] [Abstract][Full Text] [Related]
6. [The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer].
Zhang JH; Li Y; Wang R; Sarbia M; Guo W; Wen DG; Wei LZ; Chen ZF; Kuang G; Zhang LW; He M; Wu ML; Wang SJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):544-6. PubMed ID: 14669229
[TBL] [Abstract][Full Text] [Related]
7. Investigation of an NQO1 polymorphism as a possible risk and prognostic factor for chronic lymphocytic leukemia.
Begleiter A; Hewitt D; Gibson SB; Johnston JB
Leuk Res; 2009 Jan; 33(1):74-81. PubMed ID: 18676018
[TBL] [Abstract][Full Text] [Related]
8. Pesticide exposure on southwestern Taiwanese with MnSOD and NQO1 polymorphisms is associated with increased risk of Parkinson's disease.
Fong CS; Wu RM; Shieh JC; Chao YT; Fu YP; Kuao CL; Cheng CW
Clin Chim Acta; 2007 Mar; 378(1-2):136-41. PubMed ID: 17188257
[TBL] [Abstract][Full Text] [Related]
9. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
[TBL] [Abstract][Full Text] [Related]
10. Increased levels of NAD(P)H: quinone oxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: A potential biomarker of early damage in the pancreas.
Lyn-Cook BD; Yan-Sanders Y; Moore S; Taylor S; Word B; Hammons GJ
Cell Biol Toxicol; 2006 Mar; 22(2):73-80. PubMed ID: 16532285
[TBL] [Abstract][Full Text] [Related]
11. NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study.
Bock CH; Wenzlaff AS; Cote ML; Land SJ; Schwartz AG
Carcinogenesis; 2005 Feb; 26(2):381-6. PubMed ID: 15498787
[TBL] [Abstract][Full Text] [Related]
12. Role of NQO1 polymorphisms as risk factors for squamous cell carcinoma of the head and neck.
Begleiter A; Norman A; Leitao D; Cabral T; Hewitt D; Pan S; Grandis JR; Siegfried JM; El-Sayed S; Sutherland D; Ross DA; Kerr PD
Oral Oncol; 2005 Oct; 41(9):927-33. PubMed ID: 16054862
[TBL] [Abstract][Full Text] [Related]
13. The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior.
Xu LL; Wain JC; Miller DP; Thurston SW; Su L; Lynch TJ; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):303-9. PubMed ID: 11319169
[TBL] [Abstract][Full Text] [Related]
14. Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population.
Alexandrie AK; Nyberg F; Warholm M; Rannug A
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):908-14. PubMed ID: 15184245
[TBL] [Abstract][Full Text] [Related]
15. Null association of NQO1 609C>T and NQO2 -3423G>A polymorphisms with susceptibility and prognosis of Esophageal cancer in north Indian population and meta-analysis.
Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B
Cancer Epidemiol; 2012 Dec; 36(6):e373-9. PubMed ID: 22770696
[TBL] [Abstract][Full Text] [Related]
16. Association analysis of NAD(P)H:quinone oxidoreductase gene 609 C/T polymorphism with Alzheimer's disease.
Wang B; Jin F; Xie Y; Tang Y; Kan R; Zheng C; Yang Z; Wang L
Neurosci Lett; 2006 Dec; 409(3):179-81. PubMed ID: 17027152
[TBL] [Abstract][Full Text] [Related]
17. NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia.
Sirma S; Agaoglu L; Yildiz I; Cayli D; Horgusluoglu E; Anak S; Yuksel L; Unuvar A; Celkan T; Apak H; Karakas Z; Devecioglu O; Ozbek U
Pediatr Blood Cancer; 2004 Oct; 43(5):568-70. PubMed ID: 15382274
[TBL] [Abstract][Full Text] [Related]
18. NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms.
Kracht T; Schrappe M; Strehl S; Reiter A; Elsner HA; Trka J; Cario G; Viehmann S; Harbott J; Borkhardt A; Metzler M; Langer T; Repp R; Marschalek R; Welte K; Haas OA; Stanulla M
Haematologica; 2004 Dec; 89(12):1492-7. PubMed ID: 15590400
[TBL] [Abstract][Full Text] [Related]
19. Association of the NAD(P)H: quinone oxidoreductase C609T polymorphism and the risk of cervical cancer in Japanese subjects.
Niwa Y; Hirose K; Nakanishi T; Nawa A; Kuzuya K; Tajima K; Hamajima N
Gynecol Oncol; 2005 Feb; 96(2):423-9. PubMed ID: 15661231
[TBL] [Abstract][Full Text] [Related]
20. Investigation of NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in prostate cancer.
Ergen HA; Gormus U; Narter F; Zeybek U; Bulgurcuoglu S; Isbir T
Anticancer Res; 2007; 27(6B):4107-10. PubMed ID: 18225579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
